NPY and metabolic syndrome: Additionally, DHEA-S has been reported to play a role in the prevention and treatment of MetS [45], as it exerts beneficial effects by stimulating lipolysis [46], reducing overeating via blockage of neuropeptide Y (NPY) [47], and reducing human visceral fat accumulation via upregulation of adiponectin gene expression [48].